These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20971174)

  • 21. Aiming for a moving target: challenges with impactor measurements of MDI aerosols.
    Stein SW
    Int J Pharm; 2008 May; 355(1-2):53-61. PubMed ID: 18191510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the development of Respimat Soft Mist Inhaler.
    Dalby R; Spallek M; Voshaar T
    Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
    Jones SA; Martin GP; Brown MB
    Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computer controlled multi-walled carbon nanotube inhalation exposure system.
    McKinney W; Chen B; Frazer D
    Inhal Toxicol; 2009 Oct; 21(12):1053-61. PubMed ID: 19555230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation.
    Ari A; Areabi H; Fink JB
    Respir Care; 2010 Jul; 55(7):837-44. PubMed ID: 20587094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro deposition of fluticasone aerosol from a metered-dose inhaler with and without two common valved holding chambers.
    Asmus MJ; Liang J; Coowanitwong I; Vafadari R; Hochhaus G
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):204-8. PubMed ID: 11868926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the temperature of thermally generated inhalation aerosols.
    Noymer PD; Myers DJ; Cassella JV; Timmons R
    J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):11-5. PubMed ID: 20961165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved laboratory test methods for orally inhaled products.
    Mitchell JP; Nagel MW
    Ther Deliv; 2013 Aug; 4(8):1003-26. PubMed ID: 23919476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balloon-based in vitro MDI aerosol deposition experiments on the effects of mouthpiece diameter.
    Fadl A; Wang J; Yang P; Zhang Z; Cheng YS
    Inhal Toxicol; 2007 May; 19(6-7):505-15. PubMed ID: 17497529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerosol plumes: slow and steady wins the race.
    Dhand R
    J Aerosol Med; 2005; 18(3):261-3. PubMed ID: 16181000
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the protective performance of a positive pressure bio-protective clothing against viral aerosol].
    Li N; Wen ZB; Yang WH; Wang J; Li JS; Hu LF; Dong XK; Liu KY; Cao J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):67-9. PubMed ID: 22490144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine aerosol generation from thermally reversible zinc halide complexes using the Staccato system.
    Simis K; Lei M; Lu AT; Sharma KC; Hale RL; Timmons R; Cassella J
    Drug Dev Ind Pharm; 2008 Sep; 34(9):936-42. PubMed ID: 18800254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new fluorescence-based method for characterizing in vitro aerosol exposure systems.
    Steiner S; Majeed S; Kratzer G; Hoeng J; Frentzel S
    Toxicol In Vitro; 2017 Feb; 38():150-158. PubMed ID: 27664316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of film thickness on thermal aerosol generation.
    Myers DJ; Timmons RD; Lu AT; Hale RL; Solas DW; Soni P; Rabinowitz JD
    Pharm Res; 2007 Feb; 24(2):336-42. PubMed ID: 17180726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical properties of therapeutic aerosols.
    Hiller FC; Mazumder MK; Wilson JD; Renninger RG; Bone RC
    Chest; 1981 Dec; 80(6 Suppl):901-3. PubMed ID: 7307634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhalation simulation and the effects of lung environmental conditions on consumer aerosol products and NaCl aerosol.
    Halbert MK; Mazumder MK; Bond RL
    Environ Res; 1982 Dec; 29(2):263-71. PubMed ID: 7160345
    [No Abstract]   [Full Text] [Related]  

  • 38. A perspective on particulate size analysis of consumer aerosol products.
    Halbert MK
    Environ Res; 1984 Feb; 33(1):189-200. PubMed ID: 6363054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a Vortex Shaking Method for Aerosolizing Fibers.
    Ku BK; Deye G; Turkevich LA
    Aerosol Sci Technol; 2013; 47(12):1293-1301. PubMed ID: 26635428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loxapine inhalation powder (adasuve): a new and innovative formulation of an antipsychotic treatment for agitation.
    Valdes J; Shipley T; Rey JA
    P T; 2014 Sep; 39(9):621-3, 648. PubMed ID: 25210413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.